Skip to content
OpenCapital
Get started

MaxCyte MXCT Market capitalization

Market capitalization at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$7.52B+10.3%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$182.6B-2.7%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$379.6M+14.8%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$482.51M+936%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$103.2M-9.6%
PDE
Pro-Dex, Inc.PDEX
$157.48M-2.6%

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Enterprise value$133.08M-46.3%
P/S4×-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Computed from the period-end share price: $75.07M.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's market capitalization?
MaxCyte (MXCT) reported market capitalization of $75.07M in Q1 2026.
How has MaxCyte's market capitalization changed year-over-year?
MaxCyte's market capitalization decreased by 74.1% year-over-year, from $289.46M to $75.07M.
What is the long-term trend for MaxCyte's market capitalization?
Over 4 years (2021 to 2025), MaxCyte's market capitalization has grown at a -36.7% compound annual growth rate (CAGR), from $1.03B to $165.34M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.